Perceptive Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.2M Sell
41,327
-258,673
-86% -$28.1M 0.09% 90
2026
Q1
$27.7M Buy
300,000
+140,000
+88% +$14.1M 0.54% 40
2025
Q4
$16.3M Buy
+160,000
New +$14.3M 0.29% 68
2019
Q3
Sell
-6,617
Closed -$571K 114
2019
Q2
$571K Buy
+6,617
New +$505K 0.01% 93

Other funds holding GH

Perceptive Advisors's GH Position: Q2 2026 in Review

Perceptive Advisors reduced its Guardant Health (GH) stake by 86% in Q2 2026, selling an estimated $28.1M and leaving 41,327 shares worth $6.2M. The position accounts for 0.09% of the portfolio, ranked #90.

Perceptive Advisors first reported a position in GH in Q2 2019 and has held it in 4 quarters since. The position peaked at $27.7M in Q1 2026. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Perceptive Advisors held 41,327 shares of Guardant Health worth $6.2M as of Q2 2026.
  • Perceptive Advisors sold 258,673 Guardant Health shares in Q2 2026, an estimated $28.1M.
  • Guardant Health made up 0.09% of Perceptive Advisors's portfolio in Q2 2026, its #90 holding.
  • Perceptive Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 4 quarters since.
  • Perceptive Advisors's Guardant Health position peaked at $27.7M in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.